Have a feature idea you'd love to see implemented?
Let us know!
PLSE Pulse Biosciences Inc
Price (delayed)
$17.92
Market cap
$1.1B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$1.08B
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first
Highlights
The company's gross profit has surged by 100% YoY
The company's revenue has surged by 100% YoY
The net income has increased by 6% year-on-year but it has declined by 3.5% since the previous quarter
The quick ratio has dropped by 58% year-on-year and by 36% since the previous quarter
PLSE's equity has dropped by 55% year-on-year and by 26% since the previous quarter
Key stats
What are the main financial stats of PLSE
Market
Valuations
Earnings
Shares outstanding
61.29M
Market cap
$1.1B
Enterprise value
$1.08B
Price to earnings (P/E)
N/A
Price to book (P/B)
36.7
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$44.98M
EBITDA
-$43.78M
Free cash flow
-$35.54M
Per share
Balance sheet
Liquidity
EPS
-$0.79
Free cash flow per share
-$0.62
Book value per share
$0.49
Revenue per share
$0
TBVPS
$0.63
Total assets
$40.43M
Total liabilities
$13.46M
Debt
$8.64M
Equity
$26.97M
Working capital
$21.28M
Debt to equity
0.32
Current ratio
4.57
Quick ratio
4.39
Net debt/EBITDA
0.4
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-82%
Return on equity
-110.2%
Return on invested capital
-337.1%
Return on capital employed
-130.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PLSE stock price
How has the Pulse Biosciences stock price performed over time
Intraday
6.41%
1 week
0.84%
1 month
4.55%
1 year
340.29%
YTD
46.41%
QTD
2.17%
Financial performance
How have Pulse Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$46.13M
Net income
-$44.02M
Gross margin
N/A
Net margin
N/A
The company's gross profit has surged by 100% YoY
The company's revenue has surged by 100% YoY
The net income has increased by 6% year-on-year but it has declined by 3.5% since the previous quarter
The operating income has declined by 3.4% since the previous quarter
Growth
What is Pulse Biosciences's growth rate over time
Valuation
What is Pulse Biosciences stock price valuation
P/E
N/A
P/B
36.7
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PLSE's EPS is up by 34% year-on-year and by 2.5% since the previous quarter
The P/B is 164% above the last 4 quarters average of 13.9
PLSE's equity has dropped by 55% year-on-year and by 26% since the previous quarter
The company's revenue has surged by 100% YoY
Efficiency
How efficient is Pulse Biosciences business performance
PLSE's return on equity has surged by 68% year-on-year but it is down by 25% since the previous quarter
The ROA has contracted by 36% YoY and by 20% from the previous quarter
The ROIC has declined by 8% since the previous quarter
Dividends
What is PLSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PLSE.
Financial health
How did Pulse Biosciences financials performed over time
The quick ratio has dropped by 58% year-on-year and by 36% since the previous quarter
PLSE's current ratio has plunged by 57% YoY and by 35% from the previous quarter
The company's debt is 68% lower than its equity
The debt to equity has soared by 100% YoY and by 28% from the previous quarter
PLSE's equity has dropped by 55% year-on-year and by 26% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.